2011•Linchuang gandanbing zazhiRequires access

Safety and efficacy of thymosin α1 and plasma exchange in treatment of patients with chronic severe hepatitis B

Guangjun Liu

Open publisher page 0 citations

Abstract

Objective To evaluate the therapeutic effect of thymosin α1 and plasma exchange in patients with chronic severe hepatitis B.Methods Conventional treatments combined with thymosin α1 and plasma exchange in 48 patients with chronic severe hepatitis B were observed.Results After treatment,the symptoms of the patients improved significantly;The TBIL,ALT and HBV DNA were reduced obviously(P0.01,P0.01,P0.01),while ALB and PTA increased(P0.05,P0.01).34(70.8%)survived.Conciusion Thymosin α1 and plasma exchange in treatment of patients with chronic hepatitis B are safe and effective.

About this research paper

What this paper is about

Objective To evaluate the therapeutic effect of thymosin α1 and plasma exchange in patients with chronic severe hepatitis B.Methods Conventional treatments combined with thymosin α1 and plasma exchange in 48 patients with chronic severe hepatitis B were observed.Results After treatment,the symptoms of the patients improved significantly;The TBIL,ALT and HBV DNA were reduced obviously(P0.01,P0.01,P0.01),while ALB and PTA increased(P0.05,P0.01).34(70.8%)survived.Conciusion Thymosin α1 and plasma exchange in treatment of patients with chronic hepatitis B are safe and effective.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To evaluate the therapeutic effect of thymosin α1 and plasma exchange in patients with chronic severe hepatitis B.Methods Conventional treatments combined with thymosin α1 and plasma exchange in 48 patients with chronic severe hepatitis B were observed.Results After treatment,the symptoms of the patients improved significantly;The TBIL,ALT and HBV DNA were reduced obviously(P0.01,P0.01,P0.01),while ALB and PTA increased(P0.05,P0.01).34(70.8%)survived.Conciusion Thymosin α1 and plasma exchange in treatment of patients with chronic hepatitis B are safe and effective.

Key concepts: Medicine, Thymosin, Chronic hepatitis, Internal medicine, Gastroenterology, Hepatitis B, Hepatitis a virus, Hepatitis

Related papers

Back to paper searchBrowse research topicsOriginal source
Safety and efficacy of thymosin α1 and plasma exchange in treatment of patients with chronic severe hepatitis B — Research Paper | ScholarLens